Clinical trials show progress in migraine frequency, skin cancer prevention

-
3:06
’He is definitely not wild’: Cudahy police reunite lost wallaby...
-
2:00
Drone show to light up Milwaukee’s Lakefront
-
1:24
One dead after shootout with police near 6th and Reservoir Avenue
-
2:23
MPD Honor Guard preparing for Officer Corder’s funeral
-
2:55
June 3-6
-
2:31
More storms possible as we head into the holiday weekend but...
-
4:48
Golden Gals MKE bring dance and camaraderie to holiday events...
-
4:08
From couch cushion to cultural icon -- The history of the cheesehead...
-
2:09
Shorewood police officer shot while responding to scene where...
-
2:27
With $2 billion at stake, Legislature and Evers rush to get state...
-
1:33
CBS 58 Hometown Athlete: Milwaukee Barbarians spread the good...
-
2:28
Milwaukee County Independence Day celebrations underway, with...
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.